Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erik, Alestig"'
Publikováno v:
Journal of Medical Virology. 85:1148-1154
Acute hepatitis B related to injection drug use is often caused by HBV-D3, a subgenotype that probably was introduced in Western Europe in the 1960s. The aim of this study was to describe genetic change over time in injection drug use-related HBV-D3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e63a43cbbdd036251e511cd467f83e8f
https://doi.org/10.1002/jmv.23580
https://doi.org/10.1002/jmv.23580
Publikováno v:
Journal of Medical Virology. 82:1327-1333
There are eight known genotypes of hepatitis B virus, A-H, and several subgenotypes, with rather well-defined geographic distributions. HBV genotypes were evaluated in 153 serum samples from Hanoi, Vietnam. Of the 87 samples that could be genotyped,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa391619e3a4eabdded0f46878cd630c
https://doi.org/10.1002/jmv.21775
https://doi.org/10.1002/jmv.21775
Publikováno v:
Journal of Clinical Microbiology. 39:3200-3203
Mutations that prevent the expression of the hepatitis B e antigen frequently emerge in the immunoreactive phase of infection. The predominant mutation, the precore G→A-1896 mutation, is restricted by the variability at position 1858 and is rare in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25587cb0f49c5c11fa52091b38b370ba
https://doi.org/10.1128/jcm.39.9.3200-3203.2001
https://doi.org/10.1128/jcm.39.9.3200-3203.2001
Publikováno v:
Journal of medical virology. 85(7)
Acute hepatitis B related to injection drug use is often caused by HBV-D3, a subgenotype that probably was introduced in Western Europe in the 1960s. The aim of this study was to describe genetic change over time in injection drug use-related HBV-D3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::675755c5a960d5c5daee1e4007eb3f60
https://pubmed.ncbi.nlm.nih.gov/23595803
https://pubmed.ncbi.nlm.nih.gov/23595803
Autor:
Rune Wejstål, Martin Lagging, Staffan Nilsson, Thomas Wahlberg, Johan Westin, Birgitta Arnholm, Anders Eilard, Erik Alestig, Magnus Lindh, Gunnar Norkrans
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 11, Iss 1, p 124 (2011)
BMC Infectious Diseases, Vol 11, Iss 1, p 124 (2011)
Background Patients infected with hepatitis C virus (HCV) genotype 1 respond poorly to standard treatment with 50% or less achieving sustained virologic response. Predicting outcome is essential and could help avoid unnecessary treatment and reduce h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd56f0c40f9d2da5897c577edd811ab2
https://doi.org/10.1186/1471-2334-11-124
https://doi.org/10.1186/1471-2334-11-124
Autor:
Martin Lagging, Gunnar Norkrans, Magnus Lindh, Rune Wejstål, Thomas Wahlberg, Anders Eilard, Erik Alestig, Johan Westin, Kristoffer Hellstrand, Birgitta Arnholm
Publikováno v:
Journal of clinical microbiology. 45(8)
We monitored early viral response during the treatment of hepatitis C virus (HCV) infection with the aim of identifying predictors of treatment outcome. We studied 53 patients with genotype 1 infection who received 180 μg/week pegylated interferon a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a15cae1a209ebc5d8fb1a1be48fe032f
https://pubmed.ncbi.nlm.nih.gov/17581934
https://pubmed.ncbi.nlm.nih.gov/17581934
Publikováno v:
Archives of virology. 146(12)
Hepatitis B virus (HBV) is spread worldwide. Seven genotypes, A-G, have been described, differing by more than 8% of the genome. In eastern Asia and Oceania genotypes B and C are predominant. However, little is known about genotypes in Mongolia and A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b635e61e196491c5964ddfb690b820a
https://pubmed.ncbi.nlm.nih.gov/11811682
https://pubmed.ncbi.nlm.nih.gov/11811682